Drugs / Systane
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00779987 | Oct → Dec 2008 | dry eye syndrome | University of Chile | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00406510 | — | dry eye syndrome | Innovative Medical | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00565669 | Oct 2007 → Oct 2008 | dry eye syndrome | Medical University of South Carolina | Completed | No outcome recorded |
| — | NCT00345241 | Jan → Dec 2006 | keratoconjunctivitis | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
Also used as a comparator or background therapy in 10 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT01541891 Comparator | Oct 2011 → Mar 2012 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 2 | NCT00607776 Comparator | Jan → Apr 2007 | dry eye syndrome | Abbott Medical Optics | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01657253 Comparator | Nov 2013 → Feb 2015 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT01386073 Comparator | Jul 2011 → Nov 2012 | dry eye syndrome | Innovative Medical | Unknown | No outcome recorded |
| Phase 4 | NCT00620893 Comparator | Feb 2008 → May 2009 | dry eye syndrome | Bp Consulting, Inc | Completed | No outcome recorded |
| Phase 4 | NCT00622037 Comparator | Feb → May 2008 | dry eye syndrome | Bp Consulting, Inc | Completed | No outcome recorded |
| Phase 4 | NCT00627302 Comparator | Feb → Nov 2008 | myopia | Bp Consulting, Inc | Completed | No outcome recorded |
| Phase 4 | NCT00399061 Comparator | Nov 2006 → Sep 2008 | dry eye syndrome | Innovative Medical | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT01650584 Comparator | Jun → Dec 2012 | dry eye syndrome | Bausch & Lomb Incorporated | Completed | No outcome recorded |
| — | NCT00610480 Comparator | Nov 2007 → Mar 2009 | dry eye syndrome | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Systane | “Systane® is marketed as over-the-counter tear lubricating therapy in the United States under the FDA monograph.” NCT00345241 ↗ |
| Modality | Other / unclassified | “Artificial Tears (Systane, 40 microliters) will be administered at the first study visit” NCT00610480 ↗ |
| Route | Other | “patients will be administered one drop of Systane® (40 µl) or saline (40 µl) in each eye per randomization assignment.” NCT00345241 ↗ |